This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Other Respiratory Disorders, Subject name: Pediatrics
[{'content': 'Humanized monoclonal antibody that binds IgE to prevent its binding to the high affinity IgE receptor and blocking IgE mediated allergic response and inflammation in Bronchial Asthma is: \nSelect and explain. \nA. Palivizumab, B. Natalizumab, C. Omalizumab, D. Etilizumab', 'role': 'user'}, {'content': 'Answer: C \nExplanation: An anti-IgE preparation, Omalizumab, is approved by the FDA for use as an add-on therapy in children >=12 yr who have moderate to severe allergic asthma that is difficult to control.', 'role': 'assistant'}]